Stockscreener 앱 받기
3.59
206.84%
2.42
시장 영업 전:
5.41
1.82
+50.70%
전일 마감가:
$1.17
열려 있는:
$1.415
하루 거래량:
342.78M
Relative Volume:
107.38
시가총액:
$16.64M
수익:
-
순이익/손실:
$-9.32M
주가수익비율:
-0.2824
EPS:
-12.7107
순현금흐름:
$-7.30M
1주 성능:
+171.97%
1개월 성능:
+112.43%
6개월 성능:
+92.70%
1년 성능:
+28.67%
1일 변동 폭
$1.34
$4.0499
1주일 범위
$1.0805
$4.0499
52주 변동 폭
$0.952
$6.39
Tharimmune Inc Stock (THAR) Company Profile
명칭
Tharimmune Inc
전화
302-743-2995
주소
1200 ROUTE 22 EAST, BRIDGEWATER
THAR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
THAR
Tharimmune Inc
|
3.59 | 6.86M | 0 | -9.32M | -7.30M | -12.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.36 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.01 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.31 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.97 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.33 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Tharimmune Inc 주식(THAR)의 최신 뉴스
Tharimmune Inc Inc. (THAR) Price Performance: The Role of Supply and Demand - investchronicle.com
Tharimmune Skyrockets 113%—What’s Fueling This Biotech Breakout? - AInvest
Will Tharimmune’s Latest Breakthrough Impact Its Stock? - StocksToTrade
Tharimmune reports positive results for opioid countermeasure film - Investing.com
Tharimmune Reports Pharmacokinetic Simulation Results for TH104 as Prophylaxis Against Respiratory Depression from Fentanyl and Ultrapotent Opioids, Highlighting Potential Superiority Over Existing Treatments - Tacoma News Tribune
Using data filters to optimize entry into Tharimmune Inc.Buy Signal & Free Weekly Chart Analysis and Trade Guides - Newser
24-Hour Fentanyl Protection: Tharimmune's New Drug Could Revolutionize Military Defense Against Opioid Threats - Stock Titan
Is Tharimmune Inc. a candidate for recovery playProfit Target & Daily Technical Forecast Reports - Newser
Order flow analysis tools used on Tharimmune Inc.2025 Big Picture & Safe Entry Momentum Tips - Newser
What technical models suggest about Tharimmune Inc.’s comebackOil Prices & High Conviction Buy Zone Alerts - Newser
What recovery options are there for Tharimmune Inc.Stop Loss & Proven Capital Preservation Tips - Newser
How to build a dashboard for Tharimmune Inc. stockPortfolio Gains Report & Fast Gain Stock Trading Tips - Newser
Using data tools to time your Tharimmune Inc. exitWeekly Trading Summary & High Accuracy Trade Alerts - Newser
Sentiment analysis tools applied to Tharimmune Inc.Dollar Strength & AI Enhanced Execution Alerts - Newser
Tharimmune Secures Key Global Patents for TH-104, Laying Foundation for Broader Indications Following Initial Development as a National Security Medical Countermeasure Against Weaponized Fentanyl - Detroit Free Press
Using AI based signals to follow Tharimmune Inc.2025 Big Picture & Technical Buy Zone Confirmation - Newser
Can machine learning forecast Tharimmune Inc. recoveryEarnings Recap Report & Fast Entry Momentum Alerts - Newser
Analyzing drawdowns of Tharimmune Inc. with statistical toolsTrade Risk Assessment & Weekly High Momentum Picks - Newser
Multi factor analysis applied to Tharimmune Inc.2025 Technical Overview & Weekly Watchlist for Hot Stocks - Newser
Published on: 2025-08-19 06:40:05 - Newser
Chart overlay techniques for tracking Tharimmune Inc.2025 Breakouts & Breakdowns & Community Shared Stock Ideas - Newser
Visualizing Tharimmune Inc. stock with heatmapsJuly 2025 News Drivers & Short-Term High Return Strategies - Newser
News impact scoring models applied to Tharimmune Inc.2025 Price Momentum & Reliable Trade Execution Plans - Newser
Tharimmune prices $1.74 million direct offering - MSN
Will Tharimmune Inc. Recover After Recent DeclineQuarterly Market Review & Step-by-Step Swing Trade Plans - newsimpact.co.kr
Published on: 2025-08-19 05:34:39 - newsimpact.co.kr
Applying Wyckoff theory to Tharimmune Inc. stockFed Meeting & Intraday High Probability Alerts - Newser
Is Tharimmune Inc. showing insider buying2025 Major Catalysts & Real-Time Market Sentiment Alerts - thegnnews.com
What makes Tharimmune Inc. stock price move sharplyPortfolio Performance Summary & Entry Point Confirmation Signals - thegnnews.com
What’s the recovery path for long term holders of Tharimmune Inc.Quarterly Trade Report & Precise Buy Zone Tips - Newser
Chart based analysis of Tharimmune Inc. trendsJuly 2025 Levels & Weekly High Momentum Picks - Newser
Tharimmune Inc. stock trend outlook and recovery pathJuly 2025 Pullbacks & Verified Chart Pattern Signals - Newser
What machine learning models say about Tharimmune Inc.Quarterly Portfolio Review & Verified Momentum Watchlists - Newser
Can Tharimmune Inc. sustain earnings growthAnalyst Downgrade & Reliable Entry Point Trade Alerts - newsyoung.net
Using fundamentals and technicals on Tharimmune Inc.Earnings Beat & AI Enhanced Execution Alerts - Newser
Tharimmune Inc (THAR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Tharimmune Inc 주식 (THAR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Parikh Sanam | Director |
Jun 20 '25 |
Buy |
1.45 |
1,000 |
1,450 |
1,770 |
| Appajosyula Sireesh | Chief Executive Officer |
Jun 20 '25 |
Buy |
1.48 |
61,496 |
90,973 |
64,868 |
| Parikh Sanam | Director |
May 15 '25 |
Buy |
1.30 |
770 |
1,001 |
770 |
| MILBY RANDY | CEO |
Dec 19 '24 |
Buy |
2.12 |
4,600 |
9,752 |
17,534 |
| Appajosyula Sireesh | Chief Operating Officer |
Nov 13 '24 |
Buy |
2.02 |
5,000 |
10,096 |
10,758 |
| MILBY RANDY | CEO |
Oct 08 '24 |
Buy |
2.09 |
2,500 |
5,221 |
12,934 |
| Appajosyula Sireesh | Chief Operating Officer |
Oct 08 '24 |
Buy |
1.93 |
5,000 |
9,650 |
16,364 |
2.44%
0.09%
자본화:
|
볼륨(24시간):